0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Natural Killer (NK) Cell Therapeutics Market Insights and Forecast to 2028
Published Date: January 2022
|
Report Code: QYRE-Othe-183
Home | Market Reports | Business & Industrial | Pharmaceuticals & Biotech
Global Natural Killer NK Cell Therapeutics Market Insights and Forecast to 2028

Global Natural Killer (NK) Cell Therapeutics Market Insights and Forecast to 2028

Code: QYRE-Othe-183
Report
January 2022
110 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures
Natural killer cells are a type of cytotoxic lymphocyte, which is a component of the innate immune system.
Market Analysis and Insights: Global Natural Killer (NK) Cell Therapeutics Market

The global Natural Killer (NK) Cell Therapeutics market size is projected to reach US$ 1158.2 million by 2028, from US$ 255.8 million in 2021, at a CAGR of 23.7% during 2022-2028.

Fully considering the economic change by this health crisis, Mogamulizumab accounting for % of the Natural Killer (NK) Cell Therapeutics global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period.

While Cancer segment is altered to an % CAGR throughout this forecast period.
China Natural Killer (NK) Cell Therapeutics market size is valued at US$ million in 2021, while the North America and Europe Natural Killer (NK) Cell Therapeutics are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period.

As for the Europe Natural Killer (NK) Cell Therapeutics landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Natural Killer (NK) Cell Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Natural Killer (NK) Cell Therapeutics market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Natural Killer (NK) Cell Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Natural Killer (NK) Cell Therapeutics market.
Global Natural Killer (NK) Cell Therapeutics Scope and Market Size
Natural Killer (NK) Cell Therapeutics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Natural Killer (NK) Cell Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type

Mogamulizumab
Lorvotuzumab Mertansine
Others

Segment by Application

Cancer
Cardiovascular Diseases
Others

BY COMPANY

Chipscreen Biosciences
Affimed NV
Altor BioScience
Innate Pharma
Takeda
Sorrento Therapeutics
NantKwest
Bristol-Myers Squibb
NKT
Henry Ford Health Services

BY REGION

North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Natural Killer (NK) Cell Therapeutics Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Mogamulizumab
1.2.3 Lorvotuzumab Mertansine
1.2.4 Others
1.3 Market by Application
1.3.1 Global Natural Killer (NK) Cell Therapeutics Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Cancer
1.3.3 Cardiovascular Diseases
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Natural Killer (NK) Cell Therapeutics Market Perspective (2017-2028)
2.2 Natural Killer (NK) Cell Therapeutics Growth Trends by Region
2.2.1 Natural Killer (NK) Cell Therapeutics Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Natural Killer (NK) Cell Therapeutics Historic Market Size by Region (2017-2022)
2.2.3 Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Region (2023-2028)
2.3 Natural Killer (NK) Cell Therapeutics Market Dynamics
2.3.1 Natural Killer (NK) Cell Therapeutics Industry Trends
2.3.2 Natural Killer (NK) Cell Therapeutics Market Drivers
2.3.3 Natural Killer (NK) Cell Therapeutics Market Challenges
2.3.4 Natural Killer (NK) Cell Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Natural Killer (NK) Cell Therapeutics Players by Revenue
3.1.1 Global Top Natural Killer (NK) Cell Therapeutics Players by Revenue (2017-2022)
3.1.2 Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Players (2017-2022)
3.2 Global Natural Killer (NK) Cell Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Natural Killer (NK) Cell Therapeutics Revenue
3.4 Global Natural Killer (NK) Cell Therapeutics Market Concentration Ratio
3.4.1 Global Natural Killer (NK) Cell Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Natural Killer (NK) Cell Therapeutics Revenue in 2021
3.5 Natural Killer (NK) Cell Therapeutics Key Players Head office and Area Served
3.6 Key Players Natural Killer (NK) Cell Therapeutics Product Solution and Service
3.7 Date of Enter into Natural Killer (NK) Cell Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Natural Killer (NK) Cell Therapeutics Breakdown Data by Type
4.1 Global Natural Killer (NK) Cell Therapeutics Historic Market Size by Type (2017-2022)
4.2 Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Type (2023-2028)
5 Natural Killer (NK) Cell Therapeutics Breakdown Data by Application
5.1 Global Natural Killer (NK) Cell Therapeutics Historic Market Size by Application (2017-2022)
5.2 Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Natural Killer (NK) Cell Therapeutics Market Size (2017-2028)
6.2 North America Natural Killer (NK) Cell Therapeutics Market Size by Type
6.2.1 North America Natural Killer (NK) Cell Therapeutics Market Size by Type (2017-2022)
6.2.2 North America Natural Killer (NK) Cell Therapeutics Market Size by Type (2023-2028)
6.2.3 North America Natural Killer (NK) Cell Therapeutics Market Share by Type (2017-2028)
6.3 North America Natural Killer (NK) Cell Therapeutics Market Size by Application
6.3.1 North America Natural Killer (NK) Cell Therapeutics Market Size by Application (2017-2022)
6.3.2 North America Natural Killer (NK) Cell Therapeutics Market Size by Application (2023-2028)
6.3.3 North America Natural Killer (NK) Cell Therapeutics Market Share by Application (2017-2028)
6.4 North America Natural Killer (NK) Cell Therapeutics Market Size by Country
6.4.1 North America Natural Killer (NK) Cell Therapeutics Market Size by Country (2017-2022)
6.4.2 North America Natural Killer (NK) Cell Therapeutics Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Natural Killer (NK) Cell Therapeutics Market Size (2017-2028)
7.2 Europe Natural Killer (NK) Cell Therapeutics Market Size by Type
7.2.1 Europe Natural Killer (NK) Cell Therapeutics Market Size by Type (2017-2022)
7.2.2 Europe Natural Killer (NK) Cell Therapeutics Market Size by Type (2023-2028)
7.2.3 Europe Natural Killer (NK) Cell Therapeutics Market Share by Type (2017-2028)
7.3 Europe Natural Killer (NK) Cell Therapeutics Market Size by Application
7.3.1 Europe Natural Killer (NK) Cell Therapeutics Market Size by Application (2017-2022)
7.3.2 Europe Natural Killer (NK) Cell Therapeutics Market Size by Application (2023-2028)
7.3.3 Europe Natural Killer (NK) Cell Therapeutics Market Share by Application (2017-2028)
7.4 Europe Natural Killer (NK) Cell Therapeutics Market Size by Country
7.4.1 Europe Natural Killer (NK) Cell Therapeutics Market Size by Country (2017-2022)
7.4.2 Europe Natural Killer (NK) Cell Therapeutics Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size (2017-2028)
8.2 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Type
8.2.1 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Share by Type (2017-2028)
8.3 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Application
8.3.1 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Share by Application (2017-2028)
8.4 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Region
8.4.1 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Natural Killer (NK) Cell Therapeutics Market Size (2017-2028)
9.2 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Type
9.2.1 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Type (2017-2022)
9.2.2 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Type (2023-2028)
9.2.3 Latin America Natural Killer (NK) Cell Therapeutics Market Share by Type (2017-2028)
9.3 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Application
9.3.1 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Application (2017-2022)
9.3.2 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Application (2023-2028)
9.3.3 Latin America Natural Killer (NK) Cell Therapeutics Market Share by Application (2017-2028)
9.4 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Country
9.4.1 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Country (2017-2022)
9.4.2 Latin America Natural Killer (NK) Cell Therapeutics Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size (2017-2028)
10.2 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Type
10.2.1 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Share by Type (2017-2028)
10.3 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Application
10.3.1 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Share by Application (2017-2028)
10.4 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Country
10.4.1 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Chipscreen Biosciences
11.1.1 Chipscreen Biosciences Company Details
11.1.2 Chipscreen Biosciences Business Overview
11.1.3 Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Introduction
11.1.4 Chipscreen Biosciences Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022)
11.1.5 Chipscreen Biosciences Recent Developments
11.2 Affimed NV
11.2.1 Affimed NV Company Details
11.2.2 Affimed NV Business Overview
11.2.3 Affimed NV Natural Killer (NK) Cell Therapeutics Introduction
11.2.4 Affimed NV Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022)
11.2.5 Affimed NV Recent Developments
11.3 Altor BioScience
11.3.1 Altor BioScience Company Details
11.3.2 Altor BioScience Business Overview
11.3.3 Altor BioScience Natural Killer (NK) Cell Therapeutics Introduction
11.3.4 Altor BioScience Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022)
11.3.5 Altor BioScience Recent Developments
11.4 Innate Pharma
11.4.1 Innate Pharma Company Details
11.4.2 Innate Pharma Business Overview
11.4.3 Innate Pharma Natural Killer (NK) Cell Therapeutics Introduction
11.4.4 Innate Pharma Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022)
11.4.5 Innate Pharma Recent Developments
11.5 Takeda
11.5.1 Takeda Company Details
11.5.2 Takeda Business Overview
11.5.3 Takeda Natural Killer (NK) Cell Therapeutics Introduction
11.5.4 Takeda Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022)
11.5.5 Takeda Recent Developments
11.6 Sorrento Therapeutics
11.6.1 Sorrento Therapeutics Company Details
11.6.2 Sorrento Therapeutics Business Overview
11.6.3 Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Introduction
11.6.4 Sorrento Therapeutics Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022)
11.6.5 Sorrento Therapeutics Recent Developments
11.7 NantKwest
11.7.1 NantKwest Company Details
11.7.2 NantKwest Business Overview
11.7.3 NantKwest Natural Killer (NK) Cell Therapeutics Introduction
11.7.4 NantKwest Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022)
11.7.5 NantKwest Recent Developments
11.8 Bristol-Myers Squibb
11.8.1 Bristol-Myers Squibb Company Details
11.8.2 Bristol-Myers Squibb Business Overview
11.8.3 Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Introduction
11.8.4 Bristol-Myers Squibb Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022)
11.8.5 Bristol-Myers Squibb Recent Developments
11.9 NKT
11.9.1 NKT Company Details
11.9.2 NKT Business Overview
11.9.3 NKT Natural Killer (NK) Cell Therapeutics Introduction
11.9.4 NKT Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022)
11.9.5 NKT Recent Developments
11.10 Henry Ford Health Services
11.10.1 Henry Ford Health Services Company Details
11.10.2 Henry Ford Health Services Business Overview
11.10.3 Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Introduction
11.10.4 Henry Ford Health Services Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022)
11.10.5 Henry Ford Health Services Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
    Table 1. Global Natural Killer (NK) Cell Therapeutics Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
    Table 2. Key Players of Mogamulizumab
    Table 3. Key Players of Lorvotuzumab Mertansine
    Table 4. Key Players of Others
    Table 5. Global Natural Killer (NK) Cell Therapeutics Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
    Table 6. Global Natural Killer (NK) Cell Therapeutics Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Natural Killer (NK) Cell Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Natural Killer (NK) Cell Therapeutics Market Share by Region (2017-2022)
    Table 9. Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Natural Killer (NK) Cell Therapeutics Market Share by Region (2023-2028)
    Table 11. Natural Killer (NK) Cell Therapeutics Market Trends
    Table 12. Natural Killer (NK) Cell Therapeutics Market Drivers
    Table 13. Natural Killer (NK) Cell Therapeutics Market Challenges
    Table 14. Natural Killer (NK) Cell Therapeutics Market Restraints
    Table 15. Global Natural Killer (NK) Cell Therapeutics Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Natural Killer (NK) Cell Therapeutics Revenue Share by Players (2017-2022)
    Table 17. Global Top Natural Killer (NK) Cell Therapeutics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer (NK) Cell Therapeutics as of 2021)
    Table 18. Ranking of Global Top Natural Killer (NK) Cell Therapeutics Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Natural Killer (NK) Cell Therapeutics Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Natural Killer (NK) Cell Therapeutics Product Solution and Service
    Table 22. Date of Enter into Natural Killer (NK) Cell Therapeutics Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Natural Killer (NK) Cell Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type (2017-2022)
    Table 26. Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Natural Killer (NK) Cell Therapeutics Revenue Market Share by Type (2023-2028)
    Table 28. Global Natural Killer (NK) Cell Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Natural Killer (NK) Cell Therapeutics Revenue Share by Application (2017-2022)
    Table 30. Global Natural Killer (NK) Cell Therapeutics Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Natural Killer (NK) Cell Therapeutics Revenue Share by Application (2023-2028)
    Table 32. North America Natural Killer (NK) Cell Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 33. North America Natural Killer (NK) Cell Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 34. North America Natural Killer (NK) Cell Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 35. North America Natural Killer (NK) Cell Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 36. North America Natural Killer (NK) Cell Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 37. North America Natural Killer (NK) Cell Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 38. Europe Natural Killer (NK) Cell Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 39. Europe Natural Killer (NK) Cell Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 40. Europe Natural Killer (NK) Cell Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 41. Europe Natural Killer (NK) Cell Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 42. Europe Natural Killer (NK) Cell Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 43. Europe Natural Killer (NK) Cell Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 44. Asia Pacific Natural Killer (NK) Cell Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 45. Asia Pacific Natural Killer (NK) Cell Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 46. Asia Pacific Natural Killer (NK) Cell Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 47. Asia Pacific Natural Killer (NK) Cell Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 48. Asia Pacific Natural Killer (NK) Cell Therapeutics Market Size by Region (2017-2022) & (US$ Million)
    Table 49. Asia Pacific Natural Killer (NK) Cell Therapeutics Market Size by Region (2023-2028) & (US$ Million)
    Table 50. Latin America Natural Killer (NK) Cell Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 51. Latin America Natural Killer (NK) Cell Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 52. Latin America Natural Killer (NK) Cell Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 53. Latin America Natural Killer (NK) Cell Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 54. Latin America Natural Killer (NK) Cell Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 55. Latin America Natural Killer (NK) Cell Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 56. Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Size by Type (2017-2022) & (US$ Million)
    Table 57. Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Size by Type (2023-2028) & (US$ Million)
    Table 58. Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Size by Application (2017-2022) & (US$ Million)
    Table 59. Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Size by Application (2023-2028) & (US$ Million)
    Table 60. Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Size by Country (2017-2022) & (US$ Million)
    Table 61. Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Size by Country (2023-2028) & (US$ Million)
    Table 62. Chipscreen Biosciences Company Details
    Table 63. Chipscreen Biosciences Business Overview
    Table 64. Chipscreen Biosciences Natural Killer (NK) Cell Therapeutics Product
    Table 65. Chipscreen Biosciences Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022) & (US$ Million)
    Table 66. Chipscreen Biosciences Recent Developments
    Table 67. Affimed NV Company Details
    Table 68. Affimed NV Business Overview
    Table 69. Affimed NV Natural Killer (NK) Cell Therapeutics Product
    Table 70. Affimed NV Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022) & (US$ Million)
    Table 71. Affimed NV Recent Developments
    Table 72. Altor BioScience Company Details
    Table 73. Altor BioScience Business Overview
    Table 74. Altor BioScience Natural Killer (NK) Cell Therapeutics Product
    Table 75. Altor BioScience Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022) & (US$ Million)
    Table 76. Altor BioScience Recent Developments
    Table 77. Innate Pharma Company Details
    Table 78. Innate Pharma Business Overview
    Table 79. Innate Pharma Natural Killer (NK) Cell Therapeutics Product
    Table 80. Innate Pharma Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022) & (US$ Million)
    Table 81. Innate Pharma Recent Developments
    Table 82. Takeda Company Details
    Table 83. Takeda Business Overview
    Table 84. Takeda Natural Killer (NK) Cell Therapeutics Product
    Table 85. Takeda Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022) & (US$ Million)
    Table 86. Takeda Recent Developments
    Table 87. Sorrento Therapeutics Company Details
    Table 88. Sorrento Therapeutics Business Overview
    Table 89. Sorrento Therapeutics Natural Killer (NK) Cell Therapeutics Product
    Table 90. Sorrento Therapeutics Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022) & (US$ Million)
    Table 91. Sorrento Therapeutics Recent Developments
    Table 92. NantKwest Company Details
    Table 93. NantKwest Business Overview
    Table 94. NantKwest Natural Killer (NK) Cell Therapeutics Product
    Table 95. NantKwest Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022) & (US$ Million)
    Table 96. NantKwest Recent Developments
    Table 97. Bristol-Myers Squibb Company Details
    Table 98. Bristol-Myers Squibb Business Overview
    Table 99. Bristol-Myers Squibb Natural Killer (NK) Cell Therapeutics Product
    Table 100. Bristol-Myers Squibb Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022) & (US$ Million)
    Table 101. Bristol-Myers Squibb Recent Developments
    Table 102. NKT Company Details
    Table 103. NKT Business Overview
    Table 104. NKT Natural Killer (NK) Cell Therapeutics Product
    Table 105. NKT Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022) & (US$ Million)
    Table 106. NKT Recent Developments
    Table 107. Henry Ford Health Services Company Details
    Table 108. Henry Ford Health Services Business Overview
    Table 109. Henry Ford Health Services Natural Killer (NK) Cell Therapeutics Product
    Table 110. Henry Ford Health Services Revenue in Natural Killer (NK) Cell Therapeutics Business (2017-2022) & (US$ Million)
    Table 111. Henry Ford Health Services Recent Developments
    Table 112. Research Programs/Design for This Report
    Table 113. Key Data Information from Secondary Sources
    Table 114. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Natural Killer (NK) Cell Therapeutics Market Share by Type: 2021 VS 2028
    Figure 2. Mogamulizumab Features
    Figure 3. Lorvotuzumab Mertansine Features
    Figure 4. Others Features
    Figure 5. Global Natural Killer (NK) Cell Therapeutics Market Share by Application: 2021 VS 2028
    Figure 6. Cancer Case Studies
    Figure 7. Cardiovascular Diseases Case Studies
    Figure 8. Others Case Studies
    Figure 9. Natural Killer (NK) Cell Therapeutics Report Years Considered
    Figure 10. Global Natural Killer (NK) Cell Therapeutics Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Natural Killer (NK) Cell Therapeutics Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Natural Killer (NK) Cell Therapeutics Market Share by Region: 2021 VS 2028
    Figure 13. Global Natural Killer (NK) Cell Therapeutics Market Share by Players in 2021
    Figure 14. Global Top Natural Killer (NK) Cell Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Natural Killer (NK) Cell Therapeutics as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Natural Killer (NK) Cell Therapeutics Revenue in 2021
    Figure 16. North America Natural Killer (NK) Cell Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 17. North America Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 18. North America Natural Killer (NK) Cell Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 19. North America Natural Killer (NK) Cell Therapeutics Market Size Share by Country (2017-2028)
    Figure 20. United States Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Natural Killer (NK) Cell Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 23. Europe Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 24. Europe Natural Killer (NK) Cell Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 25. Europe Natural Killer (NK) Cell Therapeutics Market Size Share by Country (2017-2028)
    Figure 26. Germany Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. France Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. U.K. Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Italy Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Russia Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Nordic Countries Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. Asia-Pacific Natural Killer (NK) Cell Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 33. Asia Pacific Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 34. Asia Pacific Natural Killer (NK) Cell Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 35. Asia Pacific Natural Killer (NK) Cell Therapeutics Market Size Share by Region (2017-2028)
    Figure 36. China Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Japan Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. South Korea Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Southeast Asia Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. India Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Australia Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
    Figure 42. Latin America Natural Killer (NK) Cell Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 43. Latin America Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 44. Latin America Natural Killer (NK) Cell Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 45. Latin America Natural Killer (NK) Cell Therapeutics Market Size Share by Country (2017-2028)
    Figure 46. Mexico Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 47. Brazil Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 48. Middle East & Africa Natural Killer (NK) Cell Therapeutics Market Size YoY (2017-2028) & (US$ Million)
    Figure 49. Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Size Market Share by Type (2017-2028)
    Figure 50. Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Size Market Share by Application (2017-2028)
    Figure 51. Middle East and Africa Natural Killer (NK) Cell Therapeutics Market Size Share by Country (2017-2028)
    Figure 52. Turkey Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 53. Saudi Arabia Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 54. UAE Natural Killer (NK) Cell Therapeutics Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 55. Chipscreen Biosciences Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2017-2022)
    Figure 56. Affimed NV Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2017-2022)
    Figure 57. Altor BioScience Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2017-2022)
    Figure 58. Innate Pharma Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2017-2022)
    Figure 59. Takeda Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2017-2022)
    Figure 60. Sorrento Therapeutics Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2017-2022)
    Figure 61. NantKwest Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2017-2022)
    Figure 62. Bristol-Myers Squibb Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2017-2022)
    Figure 63. NKT Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2017-2022)
    Figure 64. Henry Ford Health Services Revenue Growth Rate in Natural Killer (NK) Cell Therapeutics Business (2017-2022)
    Figure 65. Bottom-up and Top-down Approaches for This Report
    Figure 66. Data Triangulation
    Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart

Electronic (PDF)
$4900
This license allows only one user to access the PDF.

Electronic (PDF)
$7350
This license allows multiple user to access the PDF.

Electronic (PDF)
$9800
This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Samsung SD

RELATED REPORTS

Global and United States Biologics Drug Development Market Report Forecast 2022 2028
Global and United States Biologics Drug Development Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-5X6010
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Biologics Drug Discovery Market Report Forecast 2022 2028
Global and United States Biologics Drug Discovery Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-0D6239
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Nanopharmaceutical Drugs Market Report Forecast 2022 2028
Global and United States Nanopharmaceutical Drugs Market Report & Forecast 2022-2028

The increasing prevalence of chronic diseases and development of the healthcare infrastructure are promoting the adoption of the novel medicine known as nanomedicine for better efficacy and improved patient outcome.Market Analysis and Insights Global and United States Nanopharmaceutical Drugs MarketThis report focuses on global and United States Nanopharmaceutical Drugs market also covers the segmentation data of other regions in regional level and county level.Due to the COVID19 pandemic the global Nanopharmaceutical Drugs market size is estimated to be worth US 35330 million in 2022 and is forecast to a readjusted size of US 72540 million by 2028 with a CAGR of 12.7 during the review period.

120 Pages
Type: Report
Code: QYRE-Auto-24J10248
Tue Jun 07 00:00:00 UTC 2022

Add to Cart

Global and United States Polymerase Chain Reaction Technology Market Report Forecast 2022 2028
Global and United States Polymerase Chain Reaction Technology Market Report & Forecast 2022-2028

120 Pages
Type: Report
Code: QYRE-Auto-7I6111
Tue Jun 07 00:00:00 UTC 2022

Add to Cart